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With the recent development of salivary biomarker diagnostic tests for clinical settings, the 
understanding of protein contribution measurements of serum to saliva is crucial for 
accurate clinical analyses. In this study, the development of a nano-bio-chip (NBC) 
immunoassay that quantifies transferrin in saliva, a protein found in significantly higher 
concentrations in the serum than saliva, was established. This transferrin NBC assay 
demonstrates a high level of precision, accuracy, and sensitivity and correlates well with 
the current gold standard tests, such as enzyme-linked immunosorbent assay (ELISA). In 
addition, data from the transferrin NBC test indicate that individuals with periodontal 
disease exhibit a higher salivary concentration of transferrin than healthy controls. 
Therefore, transferrin, as measured by the NBC-relevant test, may be useful as a biomarker 
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Clinical testing commonly includes the drawing of blood to determine protein 
concentrations in serum by a laboratory technician. These levels of proteins provide a 
picture to the clinician about the body’s internal condition and are used for patient 
diagnosis.  If liver cells are damaged from overuse such as during alcohol abuse, the liver 
cell walls are weakened and release the protein, alanine transaminase, into the blood. 
Alanine transaminase is usually found inside healthy liver or heart cells. The elevation of 
alanine transaminase in the blood compared to normal human levels would indicate 
possible liver damage and would warrant further testing. Proteins like alanine 
transaminase are not only useful because of their role as an indicator but often when 
grouped together with other proteins they can be used to detect the possible presence of 
certain diseases. In this second role, the protein is called a biomarker.  Clinical testing has 
used blood as the agent primarily for determining biomarkers and proteomic 
measurements; however, saliva has proven to be an equally useful biological tool.   
 Much of the saliva utility is due to its likeness to blood.1,2,3 Blood is composed of 
mostly plasma, which contains 90 percent water and dissolved proteins, electrolytes, 
carbohydrates, minerals, and fats. It also contains cell and cell fragments which are 
categorized into erythrocytes (red blood cells), leukocytes (white blood cells), and 
thrombocytes (platelets). It is also worth mentioning that some tests specify that serum 
was used and not whole blood. Serum refers to whole blood without the clotting factors. 
Similarly, saliva is composed of mostly water and then dissolved proteins, electrolytes, 
carbohydrates, minerals, and fats.6,7,8 In effect, saliva can be considered a dilute version of 




Immunoassay techniques detect and quantify biomolecules, most typically protein, 
and use molecules from the immune system, namely antibodies, in a very highly specific 
and sensitive fashion. The enzyme-linked immunosorbent assay (ELISA) is one type of 
common technique, which uses antibodies produced from B lymphocytes of the humoral 
component of the immune system, as opposed to the T lymphocytes in the cellular 
component. These antibodies bind to foreign bodies, tagging them for removal. This two-
component system is found in vertebrates and more complex invertebrates and both 
respond to antigens.  
Macrophages consume antigens and present it on the cell surface, stimulating the 
production of antibodies by B cells. B cells are specific to one type of antibody. The types of 
immunoglobulins vary depending on what its function is. These types are designated by a 
letter (example IgG). Antibodies contain a variable region, which provides specificity for a 
certain antigen. This variability is derived from exon shuffling during the production of the 
antibody. The different combination of splicing result in a high yield of varieties for 
different types of antigens. They also contain a constant region that is specific for a certain 
specie.  
Antibodies can be either poly- or monoclonal. Polyclonal antibodies are derived by a 
population of B-cells that bind to different epitopes (binding sites) on the antigen. This 
procedure takes several days and depends on the large influx of antibody production from 
a second injection of the antigen. The first injection creates a memory file in the animal so a 
second injection receives a larger and quicker response. Monoclonal antibodies stem from 




polyclonal is more cost efficient, it provides less specificity and more variability between 
different lots of product. 
During an ELISA, antigen is bound to a surface. If antigen is introduced, it then binds 
to the antibody. A detecting antibody with a covalently attached enzyme catalyzes a 
reaction to indicate concentration. Between a direct, indirect, and sandwich ELISA, the 
indirect ELISA depends on adsorption of the antigen onto the plastic mictrotiter plate. BSA 
or blocking agent barricades all remaining active spots. Then a primary antibody 
incubation tags the bound antigen. For example a rabbit antibody could be used. Then, a 
secondary antibody attaches to the primary with a HRP enzyme attached. When incubated 
with ABTS and hydrogen peroxide the resulting product can be measured at 414 nm. The 
coloration indicates concentration of the antigen. ABTS absorbs at a different wavelength 
(340nm) so does not interfere. 
This ELISA is used to quantify antigen and measure antibody in serum. It is versatile, 
simple, sensitive, and easily quantified, making it ideal. In order to use it, though, a 
calibration curve must be set up with known quantities of antigen. This curve is then used 
to compare with unknowns. 
Antibodies contain specificity within a given species. For example, a goat anti-mouse 
antibody indicates that the antibody will bind all mouse antibodies. This type of antibody 
that has been tested for specificity of a certain analyte is useful for human samples as this 
antibody would not normally bind to human antibodies.  
Salimetrics is an example of a company that currently creates saliva-based tests 
used to measure protein concentrations. Its platform consists of an Enzyme-Linked 




lymphocytes in the immune system. These antibodies are originally made to tag foreign 
objects called antigens inside the body for elimination. These tests allow the technician to 
perform at most 90 simultaneous tests (assuming that the dose response has six point and 
is completed without replication), however, tests takes typically several hours when 
incubation time is factored. It also requires an expensive and bulky plate reader. 8 
The McDevitt laboratories have worked with nanotechnology for the last ten years 
to develop miniaturized sensors called nano-bio-chips(NBC) sensor systems that are 
suitable for applications such as salivary diagnostic.9 These devices are fabricated using the 
same proven methods implemented to make electronics and have shown to be sensitive 
enough to correlate well with the current gold standard techniques. However, this 
particular NBC system is unique compared to other Lab-on-a-chip (LOC) initiatives in that 
it has already demonstrated the ability of exceptional analytical capacity for a range of 
analytes. Incorporation of the NBC with other aspects of diagnostic testing is promising for 
use with fluidic patient samples. 
 The nano-bio-chip is a hand-held device that integrates various laboratory 
techniques and machinery into a credit card sized instrument containing a selective 
membrane or an approximately 1 by 1 cm silicon chip. Very small amounts of patient 
sample are needed to obtain necessary data. This chip is then inserted into a toaster-sized 
machine that measures fluorescence using microscope optics and flow cytometry. Due to 
its size and ease of use, the lab on a chip is appropriate for point of need settings. The hand 
held glucometers that diabetic patients use may be likened to it. 
The NBC system has many redeemable qualities compared to similar assays that 




minutes, which is considered rapid compared to ELISA testings that may take over two 
hours. It also requires a small volume of sample and reagents (in the magnitude of less than 
100 ul) without compromising accuracy.  This is also comparable to ELISA, which often 
uses sample sizes in the microliter range.  The test itself is a miniaturized assay that is 
portable and convenient for users. Patients would be able to determine multiple test 
outcomes at the bedside in minutes. Due to the lower limits of detection, assays can be 
optimized so they have a higher sensitivity compared to leading ELISA tests. As a result, the 
NBC system is compatible with non-invasive strategies such as saliva that allows for better 
patient comfort. The bead-based system also allows for multi-analyte screening, and thus, 
comprehensive testing. Each chip has the capability of containing up about 20 beads. Each 
bead could contain antibodies for a different test, and so 20 tests would be performed 
simultaneously from the same sample. The outcome is a literal finger print of the patient’s 
health at that moment and would allow for more accurate and thorough clinical analysis 
and determination. Lastly, the NBC platform is a modular sensor and thus, has applications 
in proteomic, genomic, and cellular fields. The NBC has been used to proven successful in 
detecting proteins such as C-Reactive Protein (CRP) and cells such as CD4+ cells for HIV 
detection. These advantages point to the wide possible applications of the NBC assay and 
its usefulness in the medical field. 
Current studies in the McDevitt laboratories indicate that the NBC saliva-based 
biomarker tests may be suitable for use as a rapid screening method for diagnostic and 
prognostic cardiac emergencies. This means that an AMI patient may have a cardiac 
biomarker screening performed in the ambulance with results ready for analysis by the 




medical decisions and the faster the physician is able to understand the patient condition 
and begin the necessary procedures, the less damage to the vital heart tissue the patient 
will endure. However, in order to use saliva as a diagnostic fluid for systemic disease in the 
clinical settings, the contribution of blood to the measurements of protein content in saliva 
must be understood. For example, the high concentration of protein in blood could possibly 
pollute the concentration of the salivary proteins producing false positives.10 This type of 
measurement is of particular concern to those patients that may have poor oral health. An 
oral disease such as periodontitis, certain infectious diseases such as HIV, and behavior 
such as smoking all can contribute to the state of the individual’s oral health.11, 12 Thus, a 
blood contamination companion test was needed for biomarker panels such as the cardiac 
enzyme described above in order to measure the amount of blood leakage into the oral 
cavity. 
Transferrin is an iron carrying protein normally found in high concentrations 
(>1000mg/L) in the blood and low concentrations in saliva (<5mg/L).  According to 
Salimetrics elevated levels greater than 10 mg/L correlated with an increase in three other 
proteins found in low concentrations in saliva, higher concentration in the blood: cortisol, 
dehydroepiandrosterone (DHEA), and testosterone. Thus, levels of 10mg/L were 
considered an adequate amount of transferrin to constitute a high amount of blood 
contamination. The Salimetrics transferrin assay concentration range was from 0.8–66.0 
mg/L transferrin. Its high concentration in saliva is predominantly due to the leakage of 
blood directly into saliva. Thus, an NBC immunoassay for transferrin was developed to 




During preliminary testing, a noticeable difference was seen in the levels of 
transferrin in samples from those with periodontal disease and health individuals. As a 
result, a study was performed including 48 different patients to see if transferrin could be 
used an indicator, or biomarker, of periodontitis.  Periodontitis may be a particularly 
relevant disease to analyze because previous studies have shown that patients with 
periodontitis are at higher risks for cardiac disorders. 
 Thus, the validation of the NBC trasnferrin immunoassay to detect blood 
contamination in saliva is described as follows and lucrative data is given to show that 
transferrin may be found in higher levels in chronic periodontal disease patients than 

















Materials and Methods 
Patient Sample Collection 
 Approval from the Institutional Review Boards of the University of Kentucky (UK) 
and the University of Texas at Austin (UT) was granted for the following study. The 
University of Kentucky College of Dentistry collected unstimulated whole saliva for the 
periodontitis analysis while the University of Texas at Austin samples were used for NBC 
transferrin assay validation.  
 Patients accumulated saliva in the mouth for approximately two minutes, expelling 
into a test tube until a volume of approximately 5 mL was reached. Samples from the UK 
were immediately stored at -80°C for no longer than three weeks and then were shipped on 
dry ice to UT for no more than two days. Upon arrival, samples were centrifuged for ten 
seconds at 10,000 x g and then aliquoted avoiding any mucous matrices. All samples were 
then stored at -80°C. Samples from UT were collected and tested on the same day. These 
samples were filtered and then tested diluted in 1% bovine serum albumin in phosphate 
buffered saline (PBS). 
 
NBC transferrin assay 
Immunoformat 
 The NBC transferrin is composed of a “sandwich”-type bead-based immunoassay. 
Thus, a capturing antibody (polyclonal) conjugated to 2% x-linked glycosylated agarose 
beads is used to bind the target antigen analyte (transferrin), while a detecting antibody 
(polyclonal) conjugated to a fluorophore (AlexaFluor-488® by Molecular Probes) binds 





 The agarose beads used for the NBC transferrin assay were prepared in the 
McDevitt laboratory following the same protocol used in previous studies. The transferrin-
specific capture and detection antibodies were purchased from Bethyl Laboratories 
(Montgomery, TX). The transferrin used as the standards was obtained from GenWay 
Biotech, Inc. (San Diego, CA).  The AlexaFluor-488® was conjugated to the detecting 
antibody using a commercially available AlexaFluor-488® Protein Labeling Kit from 
Molecular Probes (Eugene, OR). Resulting antibodies were verified using UV light and then 
stored at -20°C in 10ul aliquots.  
Set-up 
Design, fabrication, and testing methods for the NBC system has been described in 
detail in previous reports. The NBC-based transferrin assay is a 2-site immunometric 
“sandwich-type” test performed on ~280 μm porous agarose beads, positioned in a micro-
etched array of wells on a silicon wafer/chip platform (Figure 1). Each bead within the 
array of the chip serves as an independent self-contained “micro-reactor.” Included in the 
array are agarose beads coupled to the antibody that is not specified for transferrin; these 
beads serve as negative controls. Microfluidic structures included here serve as flow cells 
that deliver a series of small-volume reagents and washes to the microchip and to each of 
the beads. The used reagents are pushed to a waste reservoir down the bottom drain 
element. Images of fluorescent beads are captured with a digital video chip and analyzed to 
facilitate detection and, ultimately, quantitation of analytes.  
 The transferrin NBC assay was performed at room temperature under a continuous 




delivered for three minutes and washed off by a one-minute PBS wash. AlexaFluor-488®-
conjugated detecting antibody was introduced for five minutes, followed by a final one 
minute PBS wash. The total NBC transferrin assay takes eleven minutes.  
 
Analysis 
 To determine the density of detecting antibody fluorescence from the NBC 
transferrin assay a software called Image Pro Plus is used to select a specific area of 
interest (AOI) around the bead following the same steps in previous studies. These 
intensities are transferred to a data spread sheet where statistical procedures are used to 
find the average signal intensity according to the intensity of multiple transferrin capturing 
beads on the same assay. Typically four redundant beads were used per sample or 
standard. A calibration curve is generated from standard concentrations daily by using a 
computer software called SigmaPlot. Sample intensity values are then compared to this 
curve using standard curve fitting protocols to determine the concentration of transferrin. 
 
NBC transferrin assay: characterization 
Limit of Detection (LOD) 
 The LOD for the NBC transferrin assay was determined at the 99.5% confidence 
level by finding the lowest antigen concentration that provided an average bead signal 
higher than at least three standard deviations above the mean value recorded for the same 






 The detection range was defined by the NBC transferrin assay’s LOD for the lower 
boundary and the transferrin standard concentration that provided an almost saturated 
bead signal intensity for the higher boundary (Figure 2). 
 
Quantitation Range 
 The quantitation range of the assay was defined as the linear portion of the dose 
response curve.  
 
Precision 
 The intra- and inter-assay precision for the NBC transferrin assay was calculated to 
describe the precision. The intra-assay precision was found from the amount of agreement 
of four beads within the same assay run for three runs at two different concentrations. 
Inter-assay precision was determined by finding the degree of agreement between 
repeated measurements of an unknown sample. The signal intensities from three runs 
were compared and precision was calculated as the percent coefficient of variation (%CV).  
 
Linearity 
 The linearity of the NBC transferrin assay was found by testing serial dilutions of a 
saliva sample and interpolating the resulting concentrations via dose response curve 
comparison.  
 





 The method comparison study was performed by comparing the accuracy of the 
NBC transferrin assay sample concentrations to those results found using the established 
commercially-available Salivary Blood Contamination ELISA Kit from Salimetrics, Inc. 
(State College, PA). Twelve samples were tested using the ELISA and NBC methods. ELISA 
dose response and samples were tested in duplicate. 
 
Periodontitis Study 
 Salivary transferrin levels in orally health and periodontal disease patients were 
tested to determine if a correlation existed with transferrin levels and disease state. The 
NBC transferrin assay was used to test samples from both types of study groups. One group 
was comprised of 29 healthy volunteers without any clinically detectable periodontal 
lesions. All volunteers had at least twenty teeth with less than 10% periodontal sites with 
bleeding upon probing, less than 2% probing depths greater than or equal to 5 mm, less 
than 1% of interproximal sites with clinical attachment loss of greater than 2 mm, no 
evidence of radiographic bone loss as determined by posterior vertical bitewings films, and 
no pocket depth sites greater than 5mm.   
 The second group was composed of 19 periodontal patients. These patients had 
determined loss of connective tissue attachment and bone around the teeth in conjunction 
with the formation of periodontal pockets due to the apical migration of the junctional 
epithelium. Specifically, they had at least twenty teeth with greater than 30% of 
periodontal sites with bleeding on probing, greater than 20% probing depths greater than 




of greater than 2mm, and evidence of radiographic bone loss as determined by posterior 


























NBC Transferrin Assay Characterization 
The LOD for the transferrin assay on the NBC system was at the low level of 0.2 ug/mL. 
The detection range of the saliva-based assay was found to be 0.2– 10 ug/mL, while the 
quantitation range was 0.1-3.0ug/ml. Both intra- and inter-assay precision of the NBC 
bead-based saliva transferrin assay were determined.  Here, NBC transferrin assay exhibits 
excellent intra-assay precision, in terms of bead to bead variation in signal intensity, at < 
0.0647 % CV. The inter-assay precision of the same assay was established at 9.25% CV 
(Figure 3). 
Furthermore, the NBC assay for transferrin measurements exhibits adequate linearity 
with an R2 value of 0.83111 (Figure 4). 
 
NBC Transferrin Assay Validation 
Methods comparison studies  
The NBC transferrin assay accuracy was determined against the reference ELISA 
method. The resulting measurements from the two platforms correlated at R2 = 0.976 for 6 
samples (Figure 5). 
 
Periodontal Disease Study 
48 saliva samples of healthy individuals and periodontal disease patients for 
transferrin were tested on the NBC transferrin assay. As shown in Figure 6, the healthy 
group demonstrated lower transferrin levels with a mean of 2.342 ug/mL compared to the 




tested using the Salimetric ELISA kit, and the periodontal group had a mean average of 
9.71ug/ml while the healthy group had an average of 3.43 ug/ml. In addition, the ELISA 
assay efficiently detected differences in transferrin levels between and within each of the 
groups tested. The transferrin values below 0.5 mg/dl defined the majority (73.9%) of 








































Discussion and Conclusions 
 
 Serum is known to contribute a portion of proteins to saliva. However, levels of 
serum proteins to the oral mucosa may sometimes be at levels high enough to compromise 
the actual biomarker concentrations found in the saliva. These instances confound the data 
used to determine the systemic state of health in a patient and pose an ethical health 
hazard. Thus, to completely understand indicators from salivary tests, knowledge of the 
contribution of serum to saliva is imperative to determine the actual biomarker salivary 
levels. It is possible in some instances to note blood contamination visibly, however, many 
samples are not visibly obvious and so must be tested by another means.  
 The NBC transferrin assay developed is efficient and inexpensive and has shown to 
be suitable for pre-screening of saliva samples to test for blood contamination via 
characterization and validation. The use of transferrin proved appropriate, as it is a protein 
found in high concentration in the blood, but low concentration in the saliva. It was also 
determined that patients with periodontitis exhibit higher salivary transferrin level than 
the patients who did not have periodontitis. This preliminary data suggests that transferrin 
may be useful as a biomarker of periodontitis.  
 In the future, the NBC transferrin assay will be multiplexed in different biomarker 
panels, starting with that composed of cardiac enzymes, to identify blood contamination in 
samples and expand the knowledge of variables involved in salivary diagnostic fluids for 










Figure 1.  In the NBC structures, “sandwich-type” immunoassays are performed on ~280 
μm porous agarose beads arrayed on a microchip. The selectivity of bead sensors is 
determined by the specificity of the antibody to which they are covalently coupled.   The 
assay steps of a typical NBC immunoassay include the sequential micro-fluidic delivery of 
antigen (ii) and detection antibody (iii) solutions with an intermittent and final wash steps 
with phosphate buffered saline (PBS). Images of fluorescent (via epi-illumination) beads 
are captured with a digital video chip and analyzed to facilitate detection and, ultimately, 





2. Characterization and validation of NBC-based assays for transferrin. Transferrin 
capturing bead images are seen on the left hand side while the Transferrin dose response 





















Conc. Run  Mean (X) Std Dev % CV (X-µ)² 
1 A 67.4434729 6.8984923 0.102285544 7.96268937 
1 B 70.119545 3.18047903 0.045357953 30.22685896 
1 C 56.3019295 2.62200844 0.04657049 69.21773478 
Data for 1.0 ug precision       
Average Intra-Assay %CV  Σ(%CV)/n 0.064737996   
Population Mean (µ) Σ(X)/n 64.62164913   
Population Variance (σ²) Σ(X-µ)²/n 35.8024277   
Population Std Dev. (σ) √σ² 5.98351299   
Inter-Assay %CV   (σ/µ)*100 9.259300978   
 
Conc. Run  Mean (X) Std Dev % CV (X-µ)² 
0.1 A 28.677515 0.717916264 0.025034117 1.869322886 
0.1 B 27.0316911 0.845437038 0.031275773 0.07761354 
0.1 C 26.2216434 1.32413365 0.050497737 1.185136542 
Data for 0.1 ug precision 
Average Intra-Assay %CV   Σ(%CV)/n 0.035602542   
Population Mean (µ) Σ(X)/n 27.31028317   
Population Variance (σ²) Σ(X-µ)²/n 1.044024322   
Population Std Dev. (σ) √σ² 1.021775084   
Inter-Assay %CV  (σ/µ)*100 3.741356609   
 
Figure 3. The range of the NBC is greater than that of the ELISA.  Inter-assay % CV for a low 
(0.1 ug/ml) (top chart) and high (1.0 ug/ml) concentration (bottom chart) of transferrin is 
lower than the ELISA. These values are well within the accepted percent for inter-assay % 








Figure 4. Transferrin linearity study on the NBC system. 
 
 
Figure 5. Transferrin levels in 20 periodontal & 23 healthy individuals on the NBC system 
and ELISA. The higher transferrin salivary level in diseased patients suggests transferrin’s 






Figure 6. Methods comparison of transferrin samples of known concentration on ELISA 
and NBC tests. The high correlation value of 0.976 indicate that the NBC is in agreement 
with those values found in the gold standard  ELISA test. 
 
 
Figure 7. Periodontal studies ELISA data. When 0.5 mg/dl is used as a cut off, the majority 
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